Radiation Responses and Resistance

International Review of Cell and Molecular Biology

Volumn 299, Issue , 2012, Pages 235-253

  Gladstone, Mara ^a   Su, Tin Tin ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cancer; DNA damage response; Ionizing radiation; Signaling pathways

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANGIOGENESIS; ARTICLE; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL GROWTH; CELL INVASION; CELL KILLING; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY; HUMAN; HYPOXIA; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY;

EID: 84866000822     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394310-1.00006-0     Document Type: Chapter

References (77)

1. Agliano A., Martin-Padura I., Mancuso P., Marighetti P., Rabascio C., Pruneri G., Shultz L.D., Bertolini F. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains. Int. J. Cancer 2008, 123(9):2222-2227.
2. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., Jones C.U., Sur R., Raben D., Jassem J., Ove R., Kies M.S., Baselga J., Youssoufian H., Amellal N., Rowinsky E.K., Ang K.K. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2006, 354(6):567-578.
3. Bouvard V., Zaitchouk T., Vacher M., Duthu A., Canivet M., Choisy-Rossi C., Nieruchalski M., May E. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene 2000, 19(5):649-660.
4. Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 1999, 96(8):4240-4245.
5. Cheng N., Brantley D.M., Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 2002, 13(1):75-85.
6. Cho C.H., Kammerer R.A., Lee H.J., Yasunaga K., Kim K.T., Choi H.H., Kim W., Kim S.H., Park S.K., Lee G.M., Koh G.Y. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 2004, 101(15):5553-5558.
7. De Bacco F., Luraghi P., Medico E., Reato G., Girolami F., Perera T., Gabriele P., Comoglio P.M., Boccaccio C. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J. Natl. Cancer Inst. 2011, 103(8):645-661.
8. Diers-Fenger M., Kirchhoff F., Kettenmann H., Levine J.M., Trotter J. AN2/NG2 protein-expressing glial progenitor cells in the murine CNS: isolation, differentiation, and association with radial glia. Glia 2001, 34(3):213-228.
9. Donner A.J., Szostek S., Hoover J.M., Espinosa J.M. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol. Cell 2007, 27(1):121-133.
10. Fan S., Wang J.A., Yuan R.Q., Rockwell S., Andres J., Zlatapolskiy A., Goldberg I.D., Rosen E.M. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 1998, 17(2):131-141.
11. Gaipa G., Coustan-Smith E., Todisco E., Maglia O., Biondi A., Campana D. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells. Haematologica 2002, 87(4):347-356.
12. Gambelli F., Sasdelli F., Manini I., Gambarana C., Oliveri G., Miracco C., Sorrentino V. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Cell Biol. Int. 2012, 36(1):29-38.
13. Gherardi E., Birchmeier W., Birchmeier C., Vande Woude G. Targeting MET in cancer: rationale and progress. Nat. Rev. Cancer 2012, 12(2):89-103.
14. Gilbert C.S., Green C.M., Lowndes N.F. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell 2001, 8(1):129-136.
15. Gladstone M., Frederick B., Zheng D., Edwards A., Yoon P., Stickel S., Delaney T., Chan D.C., Raben D., Su T.T. A translation inhibitor identified in a Drosophila screen enhances the effect of ionizing radiation and taxol in mammalian models of cancer. Dis. Model. Mech 2012.
16. Gomes N.P., Espinosa J.M. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev. 2010, 24(10):1022-1034.
17. Grusche F.A., Degoutin J.L., Richardson H.E., Harvey K.F. The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev. Biol. 2011, 350(2):255-266.
18. Gupta A., Yang Q., Pandita R.K., Hunt C.R., Xiang T., Misri S., Zeng S., Pagan J., Jeffery J., Puc J., Kumar R., Feng Z., Powell S.N., Bhat A., Yaguchi T., Wadhwa R., Kaul S.C., Parsons R., Khanna K.K., Pandita T.K. Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair. Cell Cycle 2009, 8(14):2198-2210.
19. Hall E., Giaccia A.J. Radiobiology for the Radiologist 2005, Lippincott Williams & Wilkins, Philadelphia, PA, USA.
20. Harima Y., Sawada S., Nagata K., Sougawa M., Ostapenko V., Ohnishi T. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int. J. Oncol. 2001, 18(3):493-497.
21. Harrison L.B., Chadha M., Hill R.J., Hu K., Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncol. 2002, 7(6):492-508.
22. He J., Liu Y., Xie X., Zhu T., Soules M., DiMeco F., Vescovi A.L., Fan X., Lubman D.M. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J. Proteome Res. 2010, 9(5):2565-2572.
23. He J., Liu Y., Zhu T., Zhu J., Dimeco F., Vescovi A.L., Heth J.A., Muraszko K.M., Fan X., Lubman D.M. CD90 is identified as a marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Mol. Cell. Proteomics 2011.
24. Henry R.E., Andrysik Z., Paris R., Galbraith M.D., Espinosa J.M. A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX. EMBO J. 2012, 31(5):1266-1278.
25. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284(5422):1994-1998.
26. Hori T., Kondo T., Kanamori M., Tabuchi Y., Ogawa R., Zhao Q.L., Ahmed K., Yasuda T., Seki S., Suzuki K., Kimura T. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells. J. Orthop. Res. 2010, 28(6):739-745.
27. Huang Q., Li F., Liu X., Li W., Shi W., Liu F.F., O'Sullivan B., He Z., Peng Y., Tan A.C., Zhou L., Shen J., Han G., Wang X.J., Thorburn J., Thorburn A., Jimeno A., Raben D., Bedford J.S., Li C.Y. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 2011, 17(7):860-866.
28. Ifeadi V., Garnett-Benson C. Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways. PLoS One 2012, 7(2):e31762.
29. Igarashi K., Sakimoto I., Kataoka K., Ohta K., Miura M. Radiation-induced senescence-like phenotype in proliferating and plateau-phase vascular endothelial cells. Exp. Cell Res. 2007, 313(15):3326-3336.
30. Inaba N., Kimura M., Fujioka K., Ikeda K., Somura H., Akiyoshi K., Inoue Y., Nomura M., Saito Y., Saito H., Manome Y. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells. Anticancer Res. 2011, 31(5):1653-1658.
31. Jones N., Iljin K., Dumont D.J., Alitalo K. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2001, 2(4):257-267.
32. Kargiotis O., Chetty C., Gogineni V., Gondi C.S., Pulukuri S.M., Kyritsis A.P., Gujrati M., Klopfenstein J.D., Dinh D.H., Rao J.S. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int. J. Oncol. 2008, 33(5):937-947.
33. Kargiotis O., Geka A., Rao J.S., Kyritsis A.P. Effects of irradiation on tumor cell survival, invasion and angiogenesis. J. Neurooncol. 2010, 100(3):323-338.
34. Kil W.J., Tofilon P.J., Camphausen K. Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat. Oncol. 2012, 7:25.
35. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ. Res. 2000, 86(1):24-29.
36. Kwaan H.C., McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat. Res. 2009, 148:43-66.
37. Kwak H.J., Lee S.J., Lee Y.H., Ryu C.H., Koh K.N., Choi H.Y., Koh G.Y. Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation 2000, 101(19):2317-2324.
38. Kwak H.J., So J.N., Lee S.J., Kim I., Koh G.Y. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS letters 1999, 448(2-3):249-253.
39. Lal B., Xia S., Abounader R., Laterra J. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clin. Cancer Res. 2005, 11(12):4479-4486.
40. Lee W.H., Cho H.J., Sonntag W.E., Lee Y.W. Radiation attenuates physiological angiogenesis by differential expression of VEGF, ang-1, tie-2 and ang-2 in rat brain. Radiat. Res. 2011, 176(6):753-760.
41. Li F., Huang Q., Chen J., Peng Y., Roop D.R., Bedford J.S., Li C.Y. Apoptotic cells activate the " phoenix rising" pathway to promote wound healing and tissue regeneration. Sci. Signal. 2010, 3(110):ra13.
42. Lopez J., Poitevin A., Mendoza-Martinez V., Perez-Plasencia C., Garcia-Carranca A. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 2012, 12:48.
43. Marini P., Belka C. Death receptor ligands: new strategies for combined treatment with ionizing radiation. Curr. Med. Chem. Anticancer Agents 2003, 3(5):334-342.
44. Marini P., Denzinger S., Schiller D., Kauder S., Welz S., Humphreys R., Daniel P.T., Jendrossek V., Budach W., Belka C. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo. Oncogene 2006, 25(37):5145-5154.
45. Ming M., He Y.Y. PTEN in DNA damage repair. Cancer Lett 2012.
46. Mothersill C., Seymour C. Radiation-induced bystander effects: evidence for an adaptive response to low dose exposures?. Dose-response : a publication of International Hormesis Society 2006, 4(4):283-290.
47. Mothersill C., Seymour C.B. Radiation-induced bystander effects and the DNA paradigm: an " out of field" perspective. Mut. Res. 2006, 597(1-2):5-10.
48. Mothersill C., Stamato T.D., Perez M.L., Cummins R., Mooney R., Seymour C.B. Involvement of energy metabolism in the production of 'bystander effects' by radiation. Br. Jr. Cancer 2000, 82(10):1740-1746.
49. Niemoller O., Belka C. Targeting death-receptors in radiation therapy. Results Probl. Cell Differ. 2009, 49:219-239.
50. Papapetropoulos A., Garcia-Cardena G., Dengler T.J., Maisonpierre P.C., Yancopoulos G.D., Sessa W.C. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Laboratory investigation. J. Tech. Methods Pathol. 1999, 79(2):213-223.
51. Pattje W.J., Schuuring E., Mastik M.F., Slagter-Menkema L., Schrijvers M.L., Alessi S., van der Laan B.F., Roodenburg J.L., Langendijk J.A., van der Wal J.E. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. Br. J. Cancer 2010, 102(12):1778-1785.
52. Piao L.S., Hur W., Kim T.K., Hong S.W., Kim S.W., Choi J.E., Sung P.S., Song M.J., Lee B.C., Hwang D., Yoon S.K. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett. 2012, 315(2):129-137.
53. Populo H., Lopes J.M., Soares P. The mTOR signalling pathway in human cancer. Int. J. Mol. Sci. 2012, 13(2):1886-1918.
54. Puc J., Keniry M., Li H.S., Pandita T.K., Choudhury A.D., Memeo L., Mansukhani M., Murty V.V., Gaciong Z., Meek S.E., Piwnica-Worms H., Hibshoosh H., Parsons R. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 2005, 7(2):193-204.
55. Pueyo G., Mesia R., Figueras A., Lozano A., Baro M., Vazquez S., Capella G., Balart J. Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy. Oncol. 2010, 15(9):976-986.
56. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456(7222):593-598.
57. Raben D., Helfrich B., Chan D.C., Ciardiello F., Zhao L., Franklin W., Baron A.E., Zeng C., Johnson T.K., Bunn P.A. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin. Cancer Res. 2005, 11(2 Pt 1):795-805.
58. Reynolds T.Y., Rockwell S., Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res. 1996, 56(24):5754-5757.
59. Ryoo H.D., Gorenc T., Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev. Cell 2004, 7(4):491-501.
60. Shan S., Robson N.D., Cao Y., Qiao T., Li C.Y., Kontos C.D., Garcia-Blanco M., Dewhirst M.W. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB J. 2004, 18(2):326-328.
61. Shmelkov S.V., St Clair R., Lyden D., Rafii S. AC133/CD133/Prominin-1. Int. J. Biochem. Cell Biol. 2005, 37(4):715-719.
62. Singh H., Saroya R., Smith R., Mantha R., Guindon L., Mitchel R.E., Seymour C, Mothersill C. Radiation induced bystander effects in mice given low doses of radiation in vivo. Dose-response : a publication of International Hormesis Society 2011, 9(2):225-242.
63. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63(18):5821-5828.
64. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
65. Smith J., Tho L.M., Xu N., Gillespie D.A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 2010, 108:73-112.
66. Smits V.A., Warmerdam D.O., Martin Y., Freire R. Mechanisms of ATR-mediated checkpoint signalling. Frontiers Biosci. 2010, 15:840-853.
67. Su T.T. Cellular responses to DNA damage: one signal, multiple choices. Annu. Rev. Genet. 2006, 40:187-208.
68. Su T.T. Safeguarding genetic information in Drosophila. Chromosoma 2011, 120(6):547-555.
69. Sun G., Irvine K.D. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev. Biol. 2011, 350(1):139-151.
70. Svendsen A., Verhoeff J.J., Immervoll H., Brogger J.C., Kmiecik J., Poli A., Netland I.A., Prestegarden L., Planaguma J., Torsvik A., Kjersem A.B., Sakariassen P.O., Heggdal J.I., Van Furth W.R., Bjerkvig R., Lund-Johansen M., Enger P.O., Felsberg J., Brons N.H., Tronstad K.J., Waha A., Chekenya M. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol. 2011, 122(4):495-510.
71. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., Weissman I.L. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 2000, 97(26):14720-14725.
72. Valerie K., Yacoub A., Hagan M.P., Curiel D.T., Fisher P.B., Grant S., Dent P. Radiation-induced cell signaling: inside-out and outside-in. Mol. Cancer Ther 2007, 6(3):789-801.
73. Weinert T.A., Hartwell L.H. Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage. Mol. Cell. Biol. 1990, 10(12):6554-6564.
74. Weinert T.A., Hartwell L.H. Cell cycle arrest of cdc mutants and specificity of the RAD9 checkpoint. Genetics 1993, 134(1):63-80.
75. Weinert T.A., Kiser G.L., Hartwell L.H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 1994, 8(6):652-665.
76. Wick W., Furnari F.B., Naumann U., Cavenee W.K., Weller M. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. Oncogene 1999, 18(27):3936-3943.
77. Zimmermann M., Zouhair A., Azria D., Ozsahin M. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat. Oncol. 2006, 1:11.